CHESTNUT HILL, Mass.,
May 5, 2020 /PRNewswire/
-- Sokolove Law announces an investigation into a securities
class action lawsuit filed against Inovio Pharmaceuticals
(NASDAQ: INO) on behalf of shareholders. INO investors
that purchased 20,000 shares or more between February 14 to March 9, 2020 and are interested
in learning more about the class action lawsuit
should call 800-974-3478 to explore their legal
rights. The May 12th deadline is
approaching, time is extremely limited- shareholders are encouraged
to call without delay.
For more information visit: INOFraud.com
The lawsuit alleges that between February
14, 2020 and March 9, 2020 the
defendants capitalized on extreme COVID-19 panic by falsely
claiming that Inovio Pharmaceuticals, Inc. had developed a vaccine
for COVID-19. The lawsuit also alleges that Inovio
Pharmaceuticals CEO J. Joseph Kim
appeared on Fox Business News and stated Inovio had developed a
COVID-19 vaccine. After J. Joseph
Kim's statement, the market responded favorably and Inovio's
stock price quadrupled from $4.28 a
share on February 28, 2020, and
continued to rise in subsequent weeks, reaching an intra-day high
of $19.36 on March 9, 2020. It is alleged that Inovio had not
developed a COVID-19 vaccine. The lawsuit states that on
March 9, 2020, before trading
commenced, Citron Research exposed the misstatements, calling for
an SEC investigation into the matter. In response, Inovio's stock
price fell dramatically from its March
9 opening price of $18.72 per
share to close to $9.83. The
following day, March 10, 2020,
Inovio's stock price fell from its $9.30 per share opening price to close at
$5.70 per share.
If you are an INO investor who purchased 20,000 shares or
more between February 14, 2020 to
March 9, 2020, call our experienced
case managers now at 800-974-3478 to discuss your legal rights
in this securities fraud class action lawsuit.
The class has not been certified yet. You are not represented by
an attorney until certification occurs. If you do not take action
you can remain an absent class member. There is no required minimum
number of shares to be a class member.
About Sokolove Law
Sokolove Law provides quality legal services that help people
obtain access to the civil justice system. For more than 40 years,
Sokolove Law has worked to educate people about their legal rights
and helped thousands of injured parties obtain the compensation
they deserved from their legal claims. Sokolove Law is a national
law firm with offices and a licensed attorney in nearly every
state. The firm operates as a limited liability company in all
states except Virginia,
California, Michigan and Tennessee, where it operates as a limited
liability partnership. For more information on Sokolove Law, please
visit www.sokolovelawfirm.com
THIS IS AN ADVERTISEMENT Sokolove Law, LLC, 1330 Boylston St,
Suite 400, Chestnut Hill, MA
02467. Ricky LeBlanc admitted in MA
only. While this firm maintains joint responsibility, most cases of
this type are referred to other attorneys for principal
responsibility. This is general information only and should not be
taken or relied on as legal, medical, or other advice. No
attorney-client or other professional relationship is created by
providing or using this information. Prior results do not guarantee
a similar outcome. ©2020 Sokolove Law, LLC
View original content to download
multimedia:http://www.prnewswire.com/news-releases/may-2020-deadline-approaching-for-inovio-pharmaceuticals-ino-class-action-301053210.html
SOURCE Sokolove Law, LLC